Impact of travel burden on clinical outcomes in lung cancer
Purpose Our study explores the influence of travel burden (measured as travel distance and travel time) on clinical outcomes in lung cancer patients. Methods A retrospective analysis of a single Bulgarian center was performed. A total of 9240 lung cancer patients were included in the study. Travel d...
Gespeichert in:
| Veröffentlicht in: | Supportive care in cancer 2022-06, Vol.30 (6), p.5381-5387 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5387 |
|---|---|
| container_issue | 6 |
| container_start_page | 5381 |
| container_title | Supportive care in cancer |
| container_volume | 30 |
| creator | Stoyanov, Dragomir Svetozarov Conev, Nikolay Vladimirov Donev, Ivan Shterev Tonev, Ivan Dimitrov Panayotova, Teodorika Vitalinova Dimitrova-Gospodinova, Eleonora Georgieva |
| description | Purpose
Our study explores the influence of travel burden (measured as travel distance and travel time) on clinical outcomes in lung cancer patients.
Methods
A retrospective analysis of a single Bulgarian center was performed. A total of 9240 lung cancer patients were included in the study. Travel distance and travel time between patients’ city of residence and the treating facility were calculated with an online tool to determine the shortest route for travel using the existing road network. The probability of survival was estimated using the Kaplan–Meier method, and differences in survival in each subgroup were evaluated with a log-rank test.
Results
About one third of all included patients were living in the same city as the treating facility (
n
= 2746, 29.7%). Overall survival in our patient population was significantly lower with increasing travel distance (
p
|
| doi_str_mv | 10.1007/s00520-022-06978-8 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2639227369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A701892240</galeid><sourcerecordid>A701892240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-124599b0ee1851f09fea84bbc205bac21fd4d57bff901dc60a5f388df4f42d973</originalsourceid><addsrcrecordid>eNp9kU1rFTEUhoMo9rb6B1xIwI2bqSdfNwmuStFaKHTTrkMmc3KZMpNckxnBf9-0t1oUkSwCyfO-nMNDyDsGpwxAf6oAikMHnHewtdp05gXZMClEp4WwL8kGrGSdFEodkeNa7wCY1oq_JkdCcWO0URvy-XLe-7DQHOlS_A-caL-WARPNiYZpTGPwE83rEvKMlY6JTmva0eBTwPKGvIp-qvj26T4ht1-_3Jx_666uLy7Pz666ICVfOsalsrYHRGYUi2AjeiP7PnBQvQ-cxUEOSvcxWmBD2IJXURgzRBklH6wWJ-TjoXdf8vcV6-LmsQacJp8wr9XxrbCca7G1Df3wF3qX15LadI1SynJphXqmdn5CN6aY2-7hodSdaWCmtUlo1Ok_qHYGnMeQE8axvf8R4IdAKLnWgtHtyzj78tMxcA_G3MGYa8bcozFnWuj908RrP-PwO_JLUQPEAajtK-2wPK_0n9p748qd9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2655924935</pqid></control><display><type>article</type><title>Impact of travel burden on clinical outcomes in lung cancer</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Stoyanov, Dragomir Svetozarov ; Conev, Nikolay Vladimirov ; Donev, Ivan Shterev ; Tonev, Ivan Dimitrov ; Panayotova, Teodorika Vitalinova ; Dimitrova-Gospodinova, Eleonora Georgieva</creator><creatorcontrib>Stoyanov, Dragomir Svetozarov ; Conev, Nikolay Vladimirov ; Donev, Ivan Shterev ; Tonev, Ivan Dimitrov ; Panayotova, Teodorika Vitalinova ; Dimitrova-Gospodinova, Eleonora Georgieva</creatorcontrib><description>Purpose
Our study explores the influence of travel burden (measured as travel distance and travel time) on clinical outcomes in lung cancer patients.
Methods
A retrospective analysis of a single Bulgarian center was performed. A total of 9240 lung cancer patients were included in the study. Travel distance and travel time between patients’ city of residence and the treating facility were calculated with an online tool to determine the shortest route for travel using the existing road network. The probability of survival was estimated using the Kaplan–Meier method, and differences in survival in each subgroup were evaluated with a log-rank test.
Results
About one third of all included patients were living in the same city as the treating facility (
n
= 2746, 29.7%). Overall survival in our patient population was significantly lower with increasing travel distance (
p
< 0.001, Mantel-Cox log rank) and travel time (
p
< 0.001, Mantel-Cox log rank). The 1-year OS rate according to travel distance was 27.1% in the same city group, 22.4% in < 50-km group, and 20.5% in ≥ 50-km group (p < 0.001). The corresponding values for the 5-year OS rate were 2.9%, 2.6%, and 1.4% (
p
< 0.001).
Conclusion
In this retrospective study, we discovered significant differences in the overall survival of patients with lung cancer depending on travel distance and travel time to the treating oncological facility. Despite having similar clinical and pathological characteristics (age, sex, stage at initial diagnosis, histologic subtype), the median overall survival was significantly lower in those subgroups of patients with a higher travel burden.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-022-06978-8</identifier><identifier>PMID: 35288785</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cancer ; Cancer patients ; Care and treatment ; Clinical outcomes ; Health care access ; Health services ; Health Services Accessibility ; Humans ; Life expectancy ; Lung cancer ; Lung Neoplasms - therapy ; Medical Oncology ; Medicine ; Medicine & Public Health ; Nursing ; Nursing Research ; Oncology ; Oncology, Experimental ; Original Article ; Pain Medicine ; Patient outcomes ; Rehabilitation Medicine ; Retrospective Studies ; Travel</subject><ispartof>Supportive care in cancer, 2022-06, Vol.30 (6), p.5381-5387</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-124599b0ee1851f09fea84bbc205bac21fd4d57bff901dc60a5f388df4f42d973</citedby><cites>FETCH-LOGICAL-c442t-124599b0ee1851f09fea84bbc205bac21fd4d57bff901dc60a5f388df4f42d973</cites><orcidid>0000-0003-2064-9475</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-022-06978-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-022-06978-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35288785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stoyanov, Dragomir Svetozarov</creatorcontrib><creatorcontrib>Conev, Nikolay Vladimirov</creatorcontrib><creatorcontrib>Donev, Ivan Shterev</creatorcontrib><creatorcontrib>Tonev, Ivan Dimitrov</creatorcontrib><creatorcontrib>Panayotova, Teodorika Vitalinova</creatorcontrib><creatorcontrib>Dimitrova-Gospodinova, Eleonora Georgieva</creatorcontrib><title>Impact of travel burden on clinical outcomes in lung cancer</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Purpose
Our study explores the influence of travel burden (measured as travel distance and travel time) on clinical outcomes in lung cancer patients.
Methods
A retrospective analysis of a single Bulgarian center was performed. A total of 9240 lung cancer patients were included in the study. Travel distance and travel time between patients’ city of residence and the treating facility were calculated with an online tool to determine the shortest route for travel using the existing road network. The probability of survival was estimated using the Kaplan–Meier method, and differences in survival in each subgroup were evaluated with a log-rank test.
Results
About one third of all included patients were living in the same city as the treating facility (
n
= 2746, 29.7%). Overall survival in our patient population was significantly lower with increasing travel distance (
p
< 0.001, Mantel-Cox log rank) and travel time (
p
< 0.001, Mantel-Cox log rank). The 1-year OS rate according to travel distance was 27.1% in the same city group, 22.4% in < 50-km group, and 20.5% in ≥ 50-km group (p < 0.001). The corresponding values for the 5-year OS rate were 2.9%, 2.6%, and 1.4% (
p
< 0.001).
Conclusion
In this retrospective study, we discovered significant differences in the overall survival of patients with lung cancer depending on travel distance and travel time to the treating oncological facility. Despite having similar clinical and pathological characteristics (age, sex, stage at initial diagnosis, histologic subtype), the median overall survival was significantly lower in those subgroups of patients with a higher travel burden.</description><subject>Cancer</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>Clinical outcomes</subject><subject>Health care access</subject><subject>Health services</subject><subject>Health Services Accessibility</subject><subject>Humans</subject><subject>Life expectancy</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - therapy</subject><subject>Medical Oncology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Original Article</subject><subject>Pain Medicine</subject><subject>Patient outcomes</subject><subject>Rehabilitation Medicine</subject><subject>Retrospective Studies</subject><subject>Travel</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU1rFTEUhoMo9rb6B1xIwI2bqSdfNwmuStFaKHTTrkMmc3KZMpNckxnBf9-0t1oUkSwCyfO-nMNDyDsGpwxAf6oAikMHnHewtdp05gXZMClEp4WwL8kGrGSdFEodkeNa7wCY1oq_JkdCcWO0URvy-XLe-7DQHOlS_A-caL-WARPNiYZpTGPwE83rEvKMlY6JTmva0eBTwPKGvIp-qvj26T4ht1-_3Jx_666uLy7Pz666ICVfOsalsrYHRGYUi2AjeiP7PnBQvQ-cxUEOSvcxWmBD2IJXURgzRBklH6wWJ-TjoXdf8vcV6-LmsQacJp8wr9XxrbCca7G1Df3wF3qX15LadI1SynJphXqmdn5CN6aY2-7hodSdaWCmtUlo1Ok_qHYGnMeQE8axvf8R4IdAKLnWgtHtyzj78tMxcA_G3MGYa8bcozFnWuj908RrP-PwO_JLUQPEAajtK-2wPK_0n9p748qd9A</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Stoyanov, Dragomir Svetozarov</creator><creator>Conev, Nikolay Vladimirov</creator><creator>Donev, Ivan Shterev</creator><creator>Tonev, Ivan Dimitrov</creator><creator>Panayotova, Teodorika Vitalinova</creator><creator>Dimitrova-Gospodinova, Eleonora Georgieva</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2064-9475</orcidid></search><sort><creationdate>20220601</creationdate><title>Impact of travel burden on clinical outcomes in lung cancer</title><author>Stoyanov, Dragomir Svetozarov ; Conev, Nikolay Vladimirov ; Donev, Ivan Shterev ; Tonev, Ivan Dimitrov ; Panayotova, Teodorika Vitalinova ; Dimitrova-Gospodinova, Eleonora Georgieva</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-124599b0ee1851f09fea84bbc205bac21fd4d57bff901dc60a5f388df4f42d973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cancer</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>Clinical outcomes</topic><topic>Health care access</topic><topic>Health services</topic><topic>Health Services Accessibility</topic><topic>Humans</topic><topic>Life expectancy</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - therapy</topic><topic>Medical Oncology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Original Article</topic><topic>Pain Medicine</topic><topic>Patient outcomes</topic><topic>Rehabilitation Medicine</topic><topic>Retrospective Studies</topic><topic>Travel</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stoyanov, Dragomir Svetozarov</creatorcontrib><creatorcontrib>Conev, Nikolay Vladimirov</creatorcontrib><creatorcontrib>Donev, Ivan Shterev</creatorcontrib><creatorcontrib>Tonev, Ivan Dimitrov</creatorcontrib><creatorcontrib>Panayotova, Teodorika Vitalinova</creatorcontrib><creatorcontrib>Dimitrova-Gospodinova, Eleonora Georgieva</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stoyanov, Dragomir Svetozarov</au><au>Conev, Nikolay Vladimirov</au><au>Donev, Ivan Shterev</au><au>Tonev, Ivan Dimitrov</au><au>Panayotova, Teodorika Vitalinova</au><au>Dimitrova-Gospodinova, Eleonora Georgieva</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of travel burden on clinical outcomes in lung cancer</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>30</volume><issue>6</issue><spage>5381</spage><epage>5387</epage><pages>5381-5387</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Purpose
Our study explores the influence of travel burden (measured as travel distance and travel time) on clinical outcomes in lung cancer patients.
Methods
A retrospective analysis of a single Bulgarian center was performed. A total of 9240 lung cancer patients were included in the study. Travel distance and travel time between patients’ city of residence and the treating facility were calculated with an online tool to determine the shortest route for travel using the existing road network. The probability of survival was estimated using the Kaplan–Meier method, and differences in survival in each subgroup were evaluated with a log-rank test.
Results
About one third of all included patients were living in the same city as the treating facility (
n
= 2746, 29.7%). Overall survival in our patient population was significantly lower with increasing travel distance (
p
< 0.001, Mantel-Cox log rank) and travel time (
p
< 0.001, Mantel-Cox log rank). The 1-year OS rate according to travel distance was 27.1% in the same city group, 22.4% in < 50-km group, and 20.5% in ≥ 50-km group (p < 0.001). The corresponding values for the 5-year OS rate were 2.9%, 2.6%, and 1.4% (
p
< 0.001).
Conclusion
In this retrospective study, we discovered significant differences in the overall survival of patients with lung cancer depending on travel distance and travel time to the treating oncological facility. Despite having similar clinical and pathological characteristics (age, sex, stage at initial diagnosis, histologic subtype), the median overall survival was significantly lower in those subgroups of patients with a higher travel burden.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>35288785</pmid><doi>10.1007/s00520-022-06978-8</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-2064-9475</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | Supportive care in cancer, 2022-06, Vol.30 (6), p.5381-5387 |
| issn | 0941-4355 1433-7339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2639227369 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Cancer Cancer patients Care and treatment Clinical outcomes Health care access Health services Health Services Accessibility Humans Life expectancy Lung cancer Lung Neoplasms - therapy Medical Oncology Medicine Medicine & Public Health Nursing Nursing Research Oncology Oncology, Experimental Original Article Pain Medicine Patient outcomes Rehabilitation Medicine Retrospective Studies Travel |
| title | Impact of travel burden on clinical outcomes in lung cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A31%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20travel%20burden%20on%20clinical%20outcomes%20in%20lung%20cancer&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Stoyanov,%20Dragomir%20Svetozarov&rft.date=2022-06-01&rft.volume=30&rft.issue=6&rft.spage=5381&rft.epage=5387&rft.pages=5381-5387&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-022-06978-8&rft_dat=%3Cgale_proqu%3EA701892240%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2655924935&rft_id=info:pmid/35288785&rft_galeid=A701892240&rfr_iscdi=true |